Dr. Michael Entzeroth
Chief Scientific Officer/Chief Operating Officer.
Cennerv Pharma
Cennerv Pharma
Singapore
Biography
He has more than 30 years of experience in pharmaceutical drug discovery and development. Between 2007 and 2013, he was Deputy Director of the A*STAR Experimental Therapeutics Centre. As Scientific Officer of S*BIO Pte Ltd in Singapore, from 2003 to 2006, he generated three novel oncology drug candidates that reached clinical status. Between 1999 and 2002, as Vice President of CEREP SA in France, he was a member of the Executive Management Committee and responsible for the company’s pharmacology service and discovery activities. At Boehringer Ingelheim Germany, from 1985 to 1999, he was involved in a variety of drug discovery programs in cardiovascular and CNS research. He worked on a number of drugs reaching the clinics or the market, among them is Micardis®, an antihypertensive which achieved blockbuster sales since 2006. During his career, he published more than 50 papers in peer-reviewed scientific journals.
Research Interest
Molecular Biology and Molecular Genetics
